18 November 2017
News and Views
Links and Services
A study for the Alimentary Pharmacology & Therapeutics investigates insulin sensitizers for the treatment of non-alcoholic steatohepatitis.
Non-alcoholic fatty liver disease generally has a benign course.
However, patients with n
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors